#CROI

Condomless receptive intercourse, ulcerative STIs, fisting and sharing sex toys are all linked with acquiring hepatitis C among HIV-positive...

Researchers presented results from various studies on hepatitis C treatment and care at a medical conference in Seattle.

Baby boomers have high rates of advanced liver fibrosis and cirrhosis.

While highly expensive, treating hepatitis C with the combination of Sovaldi and Olysio is still cheaper per cure than treating with interfer...

For those coinfected with HIV, waiting to begin hepatitis C treatment until liver damage progresses raises the risk of liver-related complicat...

People who coinfected with HIV and hepatitis C looking to take the HCV drug Olysio may need to change HIV medications to avoid drug-drug inte...

Harvoni yielded a 96 percent cure rate among people with genotype 1 of hepatitis C, as well as a small number of those with genotype 4.

Twelve weeks daclatasvir and Sovaldi offered a hep C 97 percent cure rate among those with genotypes 1 through 4 who were coinfected with...

Viekira Pak plus ribavirin boasts a hepatitis C cure rate in the low-90 percent range among those with genotype 1 of the virus who are coinfec...

Researchers presented findings from clinical trials of hepatitis C therapies at the 2014 Conference on Retroviruses and Opportunistic...

Low-dose daclatasvir and Olysio (simeprevir) cured a relatively high proportion of people with genotype 1b of hepatitis C, but just two thirds...

Sovaldi and ribavirin cured 75 percent of those with genotype 1 of hepatitis C in a recent trial, while treatment-naive people with genotype 3...

Dr. Douglas Dietrich on important advances in hepatitis C.

Twelve weeks of daclatasvir, asunaprevir and BMS-791325 cured more than 90% of treatment-naive people with genotype 1 of hepatitis C.

Six weeks of the combination pill of ledipasvir and Sovaldi, with or without GS-9669 or GS-9451, cured 95 to 100 percent of people with hep C...

Early results of Merck’s combination hepatitis C therapy showed comparable safety between those with or without HIV, plus near-perfect cure ra...